Clinical features of women with thrombotic microangiopathy in pregnancy: A case series from a single Japanese tertiary perinatal care center
Journal of Obstetrics and Gynaecology Research · 2023
DOI: 10.1111/jog.15790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Kanako Nagaoka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal Medicine, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Toky…. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: AMED, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Aim
Although perinatal thrombotic microangiopathy has become increasingly understood, the racial characteristics of patients with this condition remain unclear. Herein, we report the characteristics of patients with perinatal thrombotic microangiopathy at a single institution in Japan.
Methods
We conducted a retrospective study over a 5‐year period from January 1, 2017, to December 31, 2021, using the electronic medical records of pregnant women who delivered at the perinatal center of our hospital. We extracted the data of those who developed perinatal thrombotic microangiopathy and evaluated their characteristics at the time of disease onset, final diagnosis, and maternal and fetal outcomes.
Results
Of the 10 224 deliveries that occurred during the 5‐year period, only seven patients (0.06%) had perinatal thrombotic microangiopathy. The median pre‐pregnant body mass index was 18.65 kg/m 2 (minimum 17.3 kg/m 2 , maximum 20.7 kg/m 2 ). More than half of the patients were conceived by in‐vitro fertilization, and 42% these had twin deliveries. Four patients had a history of rheumatic disease. The other three patients without underlying diseases developed thrombotic microangiopathy with HELLP syndrome, and one patient transitioned to atypical hemolytic uremic syndrome.
Conclusions
Based on low body mass index and in‐vitro fertilization, which are characteristic of Japanese women, medical complications and twin pregnancies may be a risk for thrombotic microangiopathy. Additionally, depending on the cause of thrombotic microangiopathy, its timing and onset differed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maternal Medicine, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
- Department of Obstetrics, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
ORCID-Profile: Kayoko Kaneko, Nobuaki Ozawa
Förderung
- AMED
- Japan Agency for Medical Research and Development
Zitieren
APA
Nagaoka, K., Kaneko, K., Miyagawa, E., Abe, S., Kohno, C., Tsurane, K., Mito, A., Ozawa, N., Sago, H., Arata, N., & Murashima, A. (2023). Clinical features of women with thrombotic microangiopathy in pregnancy: A case series from a single Japanese tertiary perinatal care center. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15790
Vancouver
Nagaoka K, Kaneko K, Miyagawa E, Abe S, Kohno C, Tsurane K, et al. Clinical features of women with thrombotic microangiopathy in pregnancy: A case series from a single Japanese tertiary perinatal care center. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15790
BibTeX
@article{Nagaoka2023,
author = {Nagaoka, Kanako and Kaneko, Kayoko and Miyagawa, Eiko and Abe, Sawako and Kohno, Chie and Tsurane, Kotoyi and Mito, Asako and Ozawa, Nobuaki and Sago, Haruhiko and Arata, Naoko and Murashima, Atsuko},
title = {Clinical features of women with thrombotic microangiopathy in pregnancy: A case series from a single Japanese tertiary perinatal care center},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2023},
doi = {10.1111/jog.15790}
}
EUVIMED